Suvretta Capital Management »

Satellos Bioscience shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Satellos Bioscience shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Satellos Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Satellos Bioscience held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Satellos Bioscience by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 475k 5.63

More positions owned by Suvretta Capital Management

Arcutis Biotherapeutics (ARQT)
Veradermics Common Stock
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Palvella Therapeutics Inc Ne (PVLA)
Apellis Pharmaceuticals (APLS)
Legend Biotech Corp Sponsored Ads (LEGN)
Benitec Biopharma Com New (BNTC)
Capricor Therapeutics Com New (CAPR)
Immatics SHS (IMTX)
Arcus Biosciences Incorporated (RCUS)
Eyepoint Com New (EYPT)
Arrivent Biopharma (AVBP)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)

View all positions for Suvretta Capital Management

Top funds holding Satellos Bioscience

Franklin Resources
Vivo Capital
Point72 Asset Management
Woodline Partners
Sphera Funds Management
Suvretta Capital Management
Soleus Capital Management
Avidity Partners Management
Millennium Management
683 Capital Management
Empery Asset Management
ADAR1 Capital Management
Citadel Advisors
Hrt Financial
Morgan Stanley

View all funds holding Satellos Bioscience